ribavirin has been researched along with Guillain-Barre Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alric, L; Aronica, EMA; Ayo-Martin, AC; Cao, W; Dalton, HR; de Man, RA; de Vrij, FMS; de Zeeuw, CI; Huang, F; Jacobs, BC; Kamar, N; Kushner, SA; Lin, Z; Marie Peron, J; Metselaar, HJ; Pan, Q; Peppelenbosch, MP; Sprengers, D; van der Kroeg, M; van Eijk, JJ; Wang, W; Wang, Y; Xu, L; Yin, Y; Zhao, M; Zhou, X | 1 |
| Arné-Bes, MC; Del Bello, A; Kamar, N; Lavayssière, L | 1 |
2 other study(ies) available for ribavirin and Guillain-Barre Syndrome
| Article | Year |
|---|---|
Hepatitis E Virus Infects Neurons and Brains.
Topics: Adult; Aged; Animals; Antiviral Agents; Brain; Cell Line, Tumor; Cerebrospinal Fluid; Female; Guillain-Barre Syndrome; Hepatitis E; Hepatitis E virus; Humans; Interferon-alpha; Liver; Macaca mulatta; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Neurons; Ribavirin; RNA, Viral; Virus Replication; Virus Shedding | 2017 |
Hepatitis E virus-induced severe myositis.
Topics: Aged; Antiviral Agents; Guillain-Barre Syndrome; Hepatitis E; Hepatitis E virus; Humans; Male; Myositis; Ribavirin; Severity of Illness Index; Treatment Outcome | 2012 |